Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Science and technology in Israel"
Leadership
Prof. Andrew Viterbi's donation is the Technion's largest ever by a US citizen.
StartUps
The Technion’s New ‘Start-uP MBA’ Program Will Focus on Practical Application of Entrepreneurship, Innovation and Technology Management. The Technion-Israel Institute of Technology, one of...
Business
In the three way takeover battle Mylan is getting nervous.
Business
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Business
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Business
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
Leadership & A-List
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
Business
Mylan's filing on executive compensation reveals much higher pay than at Teva.